Sir Harpal Kumar

Sir Harpal Kumar is the President of Biopharma at Grail, where he advocates for innovative cancer detection technologies. He recently spoke about the promising results from the Galleri blood test, which could enhance early detection of aggressive cancers, potentially transforming cancer screening practices and treatment approaches.